World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
70
Citations
27947
World Ranking
6861
National Ranking
3166

Daniel S. Ory publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Daniel S. Ory sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 221 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Daniel S. Ory D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Daniel S. Ory sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 70 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 2008 - Fellow of the American Association for the Advancement of Science (AAAS)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Daniel S. Ory is affiliated with Washington University in St. Louis in the United States. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, and Medicine, focusing notably on subfields such as Molecular Biology, Physiology, Genetics, Surgery, and Biochemistry.

The body of research conducted includes contributions to several key topics, including:

  • Lysosomal Storage Disorders Research
  • RNA regulation and disease
  • Virus-based gene therapy research
  • CRISPR and Genetic Engineering
  • Cholesterol and Lipid Metabolism
  • Lipid metabolism and biosynthesis
  • Peroxisome Proliferator-Activated Receptors

They have frequently published in journals such as Journal of Lipid Research, Nature Communications, Journal of Clinical Investigation, Gene Therapy, and Molecular Therapy, with multiple publications in select venues:

  • Journal of Lipid Research (3 publications)
  • Nature Communications (2 publications)
  • Journal of Clinical Investigation
  • Gene Therapy
  • Molecular Therapy

Selected recent papers include:

  • "Krabbe disease successfully treated via monotherapy of intrathecal gene therapy" (2020, Journal of Clinical Investigation)
  • "A novel gene editing system to treat both Tay-Sachs and Sandhoff diseases" (2020, Gene Therapy)
  • "Enhanced Efficacy and Increased Long-Term Toxicity of CNS-Directed, AAV-Based Combination Therapy for Krabbe Disease" (2020, Molecular Therapy)
  • "Circulating ceramide ratios and risk of vascular brain aging and dementia" (2020, Annals of Clinical and Translational Neurology)
  • "Monitoring the itinerary of lysosomal cholesterol in Niemann-Pick Type C1-deficient cells after cyclodextrin treatment" (2020, Journal of Lipid Research)

Frequent collaborators include:

  • Xuntian Jiang
  • Jean E. Schaffer
  • Rohini Sidhu
  • Sarah E. Gale
  • Mingxing Qian

Throughout their career, Daniel S. Ory has been recognized with awards such as the Fellow of the American Association for the Advancement of Science (AAAS) in 2008, and membership in the Association of American Physicians.

Best Publications

  • In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector

    Luigi Naldini;Ulrike Blömer;Philippe Gallay;Daniel Ory

  • Triglyceride accumulation protects against fatty acid-induced lipotoxicity

    Laura L. Listenberger;Xianlin Han;Sarah E. Lewis;Sylvaine Cases

  • A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes

    Daniel S. Ory;Beverly A. Neugeboren;Richard C. Mulligan

  • Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection

    Marceline Côté;John Misasi;John Misasi;Tao Ren;Anna Bruchez

  • Palmitate-induced apoptosis can occur through a ceramide-independent pathway.

    Laura L. Listenberger;Daniel S. Ory;Jean E. Schaffer

  • Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death

    Nica M. Borradaile;Xianlin Han;Jeffrey D. Harp;Sarah E. Gale

  • miR-33 links SREBP-2 induction to repression of sterol transporters

    Tyler J. Marquart;Ryan M. Allen;Daniel S. Ory;Ángel Baldán

  • Transgenic Expression of Fatty Acid Transport Protein 1 in the Heart Causes Lipotoxic Cardiomyopathy

    Hsiu-Chiang Chiu;Attila Kovacs;Robert M. Blanton;Xianlin Han

  • Chronic Cyclodextrin Treatment of Murine Niemann-Pick C Disease Ameliorates Neuronal Cholesterol and Glycosphingolipid Storage and Disease Progression

    Cristin D. Davidson;Nafeeza F. Ali;Matthew C. Micsenyi;Gloria Stephney

  • Erk Is Essential for Growth, Differentiation, Integrin Expression, and Cell Function in Human Osteoblastic Cells

    Chung-Fang Lai;Lala Chaudhary;Aurora Fausto;Linda R. Halstead

  • Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex

    Brian M. Castellano;Ashley M. Thelen;Ofer Moldavski;McKenna Feltes

  • Cholesterol Oxidation Products Are Sensitive and Specific Blood-Based Biomarkers for Niemann-Pick C1 Disease

    Forbes D. Porter;David E. Scherrer;Michael H. Lanier;S. Joshua Langmade

  • Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial

    Daniel S Ory;Elizabeth A Ottinger;Nicole Yanjanin Farhat;Kelly A King

  • A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma

    Xuntian Jiang;Rohini Sidhu;Forbes D. Porter;Nicole M. Yanjanin

  • Fatty acid synthesis configures the plasma membrane for inflammation in diabetes

    Xiaochao Wei;Haowei Song;Li Yin;Michael G. Rizzo

  • Impaired Cholesterol Efflux in Senescent Macrophages Promotes Age-Related Macular Degeneration

    Abdoulaye Sene;Aslam A. Khan;Douglas Cox;Rei E.I. Nakamura

  • NPC1 and NPC2 regulate cellular cholesterol homeostasis through generation of low density lipoprotein cholesterol-derived oxysterols.

    Andrey Frolov;Sarah E. Zielinski;Jan R. Crowley;Nicole Dudley-Rucker

  • Small Nucleolar RNAs U32a, U33, and U35a Are Critical Mediators of Metabolic Stress

    Carlos I. Michel;Christopher L. Holley;Benjamin S. Scruggs;Rohini Sidhu

  • Consensus clinical management guidelines for Niemann-Pick disease type C.

    Tarekegn Geberhiwot;Alessandro Moro;Andrea Dardis;Uma Ramaswami

  • ER-lysosome contacts enable cholesterol sensing by mTORC1 and drive aberrant growth signalling in Niemann-Pick type C.

    Chun Yan Lim;Oliver B. Davis;Hijai R. Shin;Justin Zhang

Frequent Co-Authors

Jean E. Schaffer
Jean E. Schaffer Harvard University
Forbes D. Porter
Forbes D. Porter National Institutes of Health
Douglas F. Covey
Douglas F. Covey Washington University in St. Louis
Steven U. Walkley
Steven U. Walkley Albert Einstein College of Medicine
Paul H. Schlesinger
Paul H. Schlesinger Washington University in St. Louis
Jean-François Guillemoles
Jean-François Guillemoles Centre national de la recherche scientifique, CNRS
Mark S. Sands
Mark S. Sands Washington University in St. Louis
William J. Pavan
William J. Pavan National Institutes of Health
Nathan A. Baker
Nathan A. Baker Pacific Northwest National Laboratory
Xianlin Han
Xianlin Han The University of Texas Health Science Center at San Antonio

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online options for Biology and Biochemistry can open up flexible career pathways. Many students begin their journey with foundational credentials, like a biology degree, before branching out into healthcare roles or advanced scientific research. For those seeking a fast track, a bs in biology online offers accelerated programs, letting you graduate sooner and enter the workforce more quickly.

If your interests shift toward patient care, you might consider jobs in allied health. Financial access is a common concern, but there are financial aid for medical assistant programs options available, which make it easier to get started without heavy debt. Medical assistants interested in expanding their skill set can also look at cma to lpn bridge programs online, providing a pathway to more advanced nursing roles.

For those laser-focused on a nursing career, pursuing online associate rn programs is a flexible route. These programs let students balance studies with work or family commitments, making a career in healthcare more accessible than ever.

Best Scientists Citing Daniel S. Ory

Trending Scientists

Recently Published Articles